Countries North America
Noetik Secures $40M in Oversubscribed Series A to Advance AI-Driven Cancer Therapeutics
Noetik, an AI-native biotech company leveraging self-supervised machine learning and high-throughput spatial data to develop next-generation cancer therape...
September 02, 2024 | News
Biocon Biologics Secures Market Access for Bmab 1200 in Europe, UK, Canada, and Japan Through Janssen Settlement
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd , announced that the Company has signed a settleme...
August 29, 2024 | News
Cygnus Technologies and TriLink BioTechnologies Collaborate to Launch Cutting-Edge AccuRes™ Host Cell DNA Quantification Kits
Cygnus Technologies (Cygnus), TriLink BioTechnologies (TriLink®), both part of Maravai LifeSciences (NASDAQ: MRVI) have collaborated to ...
August 29, 2024 | News
Propanc Biopharma Secures Canadian Patent for PRP Proenzyme Composition, Strengthening Global IP Portfolio
-Propanc Biopharma, Inc. a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer,&n...
August 16, 2024 | News
Andelyn Biosciences Partners with Broad Institute to Enhance Gene Therapy Platform with MyoAAV Plasmids
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has entere...
August 07, 2024 | News
Agilent Acquires BIOVECTRA for $925 Million, Expanding Biopharma Capabilities
Agilent Technologies Inc. announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturing...
July 23, 2024 | News
DiscGenics Receives FDA Approval to Proceed with Phase III Clinical Trials for Regenerative Cell Therapy for Lumbar Degenerative Disc Disease
DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for musculoske...
July 23, 2024 | News
CordenPharma Announces €900 Million Investment to Expand Peptide Manufacturing Capabilities in US and Europe
CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its Peptide technol...
July 17, 2024 | News
Jubilant Radiopharma Invests $50 Million to Expand PET Radiopharmaceutical Manufacturing Facilities in the U.S.
Jubilant Radiopharma’s Radiopharmacies division is excited to announce an investment of $50 million (USD) to expand its PET radiopharmaceutical manuf...
June 25, 2024 | News
Wisp Expands Telehealth Services with New Fertility Vertical to Support Women Trying to Conceive
Wisp, the fastest growing sexual and reproductive telehealth provider in the U.S, today announced a new fertility vertical consisting of several products a...
June 13, 2024 | News
Sartorius Opens New $100 Million Bioanalytics Center in Ann Arbor
The life science group Sartorius opened its new Center of Excellence for bioanalytics in Ann Arbor, Michigan, two years after breaking ground in ...
June 06, 2024 | News
Enzene Biosciences Launches New Drug Discovery Division, Expands CDMO Services Amid Growing Biotech Demands
Enzene Biosciences, a leading global CDMO known for its flagship fully-connected continuous manufacturing platform (EnzeneXTM) today announces the launch o...
May 30, 2024 | News
Providence Therapeutic Holdings and Ontario Institute for Cancer Research Announce Landmark Collaboration for mRNA Drug Discovery and Development
Providence Therapeutic Holdings Inc. ("Providence"), a messenger RNA (mRNA) and lipid nanoparticle platform company engaged in the development of vaccines ...
May 24, 2024 | News
CAS Unveils CAS BioFinder Discovery Platform™ to Transform Drug Discovery Process
CAS, a division of the American Chemical Society specializing in scientific knowledge management, announced the launch of the CAS BioFinder Discovery Platf...
May 22, 2024 | News
Most Read
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
